Amongst clinical users, 96% were satisfied with our solutions’ ease of use.1
Philips provides you two clinically validated indices for coronary physiology: iFR or FFR modalities. Learn how to guide PCI with your choice.
Decide, guide, and confirm the right treatment and PCI strategy for each patient with Philips Coronary IVUS.
Effective, efficient treatment in coronary artery disease. Access clinical insights and increase confidence in treatment while reducing procedure time.
[1] D434401. Evaluated with clinical users in a simulated environment. [2] Hennessey B. et al. Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial. EuroIntervention, 2024;20:e198-e206 [3] These results were obtained during an independent survey performed between July and December 2022. The survey involved 38 participants from 6 countries spread over technologist, nurses and physicians. Questions were asked to participants that had relevant working experience in both a Philips Integrated Coronary Suite (combination of Azurion, IntraSight and Philips Hemo, Eagle Eye, Refinity and OmniWire) and a multi-vendor coronary cath lab (A multi-vendor lab is a cath lab where the equipment needed to perform the procedures is not supplied by a single vendor). The main objective was to evaluate the benefits of a Philips Integrated Coronary Suite compared to a multi-vendor lab.
You are about to visit a Philips global content page
Continue